

Leave no stone unturned
The Briefing
In her second interview with Monocle, Susanne Schaffert says that, while she is impressed with the advances in cancer research, she is also fully aware of the need for new treatments and access and that her team will leave no stone unturned to develop new therapies and work on helping patients to receive the medicines they need. While innovation will be key to achieving this goal, she says that cultivating a disruption mindset will be just as important if the word cancer is to be consigned to the history books.
Published on 23/08/2021
Thanks for reading Live.Magazine
Stay connected by subscribing to our newsletter
SubscribeBy submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.




